Streetwise Reports' Article Archives — November 2021 back to current month (96)
ImmunoGen Inc. shares traded 30% higher after the company announced positive topline data from its pivotal Phase 3 SORAYA Trial of mirvetuximab soravtansine in platinum-resistant ovarian cancer.
PennyQueen, an investor and stock market social media community builder who focuses mostly on clean tech, explains why she has invested in this uranium company and recommended it to her social media following.
Aurania Resources in a Fire Sale (11/30/2021)
Bob Moriarty of 321 Gold profiles Aurania Resources and explains why he believes its stock is attractively priced right now.
Oramed Pharmaceuticals' oral vaccine offers "convenience and safety advantages as well as coverage of emergent variant strains," noted a Nov. 29, 2021 H.C. Wainwright & Co. report.
Just a few days after the WHO deemed the COVID-19 Omicron variant a serious global health concern, leading mRNA-based vaccine developers BioNTech and Pfizer, along with rival Moderna, advised that if needed, the companies would be capable of developing a vaccine for the new mutating strains within roughly 100 days. H.C. Wainwright & Co. commented in a research note that it reiterates its "Buy" rating for BioNTech SE.
Argentina Lithium seems to be making the most of the ongoing lithium frenzy by battery producers, raising sufficient capital to fund exploration for their Argentinian lithium projects, scheduled for next quarter.
VOX Royalty - A Smart Way to Hedge Inflation Risk (11/30/2021)
Vox Royalty is completing a banner year on its royalty portfolio, executing its royalty acquisition strategy, as the company now is on the cusp of having five producing royalty assets.
Metallic Minerals has just completed its most expansive drill program on the flagship ultra high-grade Keno Silver Project, located in the prolific Keno Silver District. In addition, the company has updates on the La Plata gold-silver-copper project, and the Klondike Alluvial Gold Projects.
Shares of NRx Pharmaceuticals Inc. traded 50% higher after the company commented on new data released by the Israel Institute for Biological Research regarding the effectiveness of its BriLife® COVID-19 Vaccine against the SARS-CoV-2 "Delta" variant.
Phenom Resources' new drill results at its Carlin asset showed features of a Carlin-type system, but the grades were low, a Red Cloud Securities report noted.
Shares of Krystal Biotech Inc. reached a new 52-week high after the company reported it met both primary and secondary endpoints in its pivotal GEM-3 trial of VYJUVEK™ in patients diagnosed with Dystrophic Epidermolysis Bullosa, a rare and severe skin disease.
Standard Lithium had a remarkable week, as it got struck by a short selling report on November 18, and announced a US$100M investment by Koch Strategic Platforms on November 24. At the same time, lithium product prices don't seem to be slowing down anytime soon and set another record.
Defense Metals Delivers Excellent PEA (11/28/2021)
Bob Moriarty of 321Gold discusses Defense Metals' recent PEA and explains why this company is important for the Western EV market.
The Consortium just received government funding for a pilot project in a Scottish Distillery, enabling the switch from fuel oil to sustainable hydrogen energy technology. Jericho Energy Venture’s revolutionary, clean-tech hydrogen boiler is critical to the project.
Standard Lithium Ltd.'s shares rose 22% after the firm reported that a Koch Investments Group subsidiary has agreed to make a strategic investment in the company of CA$127.07 million via a direct private placement.
BioResearchAlert looks at Usha Resources as it looks to begin drilling at the Lost Basin Gold-Copper Project.
Adrian Day, in the Global Analyst newsletter, discusses Franco-Nevada's diversification of royalty assets, as well as providing updates on other precious metals companies he follows, including one strong buy.
Deja Vu in the World of Junior Mining (11/23/2021)
Precious metals expert Michael Ballanger takes a look at the markets and homes in on one company in particular.
With most of the easy to find mineral deposits already uncovered, KoBold, Azincourt Energy, and Fobi are turning to artificial intelligence to guide exploration. While KoBold is privately held — by the likes of Bill Gates and Jeff Bezos — Azincourt Energy and Fobi offer investors with more modest portfolios access to AI-based exploration.
Streetwise recently caught up with Peter Flindell, Vice President of Exploration, to discuss the pending offering and Goldshore's plans for the funds.
Vonage Holdings Corp. shares traded 27% higher after the company reported it entered into an agreement to be acquired by L.M. Ericsson in an all-cash deal for $21.00 per share.
Argentina Lithium & Energy’s V.P of Exploration Miles Rideout has a plan to meet surging global demand from the battery sector.
Silver Wolf Exploration will be conducting the first modern exploration program on the project.
Shares of Longeveron Inc. traded 50% higher after the company reported that the U.S. FDA approved its Lomecel-B for Rare Pediatric Disease Designation to treat a rare and life-threatening defect in infants called Hypoplastic Left Heart Syndrome.
Streetwise spoke with Raymond Pomroy, CEO of SoLVBL, and investor and advisor to SoLVBL, Rahim Allani, to learn more about the company's new security technology "Q by SoLVBL."
Emerita Resources Corp. recently announced encouraging step-out drilling results from its Iberia Belt West property in Spain. The firm is now activating three new diamond drilling rigs to accelerate exploration work. Clarus Securities Inc. commented in a research note that it is maintaining its "Speculative Buy" rating for the company and due to higher commodity market prices is raising its price target for the firm's shares to CA$5.00.
Where Is U.S. Global Investors Investing Now? (11/18/2021)
U.S. Global Investors, which has historically focused on resource and precious metals investing prior to launching its global airlines ETF in 2015, is now branching out to a new sector. Streetwise Reports speaks to Frank Holmes, CEO and Chief Investment Officer, who discusses the path ahead for gold as well as the new investment area for the firm that he believes global economic imbalances have primed for profits.
This Microcap With Gold-Silver Assets Is a Buy (11/18/2021)
Microcap gold stocks offer investors exposure to gold’s upside in an inflationary environment while providing a bit of fun as your position rides the waves of investor confidence. An expert analyst has made Inomin Mines Inc. his latest pick. As long as you can stomach the risk, the ride could pay off with much more than what you put into it.
"Today's results from Liberty Gold show the growth potential inherent in the providence of the gold mineralized system on the project area," noted a Haywood Securities report.
Shares of Dicerna Pharmaceuticals Inc. traded 78% higher after the company reported it entered into a definitive agreement to be acquired by Novo Nordisk A/S of Denmark for $38.25 per share in cash.
"This first stream represents an important milestone in terms of opportunities originated by Nomad Royalty Company since inception," noted a BMO Capital Markets report.
"Given this actual and expected strong balance sheet, we expect Teck Resources could announce a one-time capital return to shareholders with its February earnings and guidance release," noted a BMO Capital Markets report.
Daybreak in the Land of Precious Metals (11/17/2021)
Michael Ballanger dissects last week's price gains in gold and silver.
West Wits About to Begin Gold Production (11/17/2021)
According to Bob Moriarty of 321Gold, West Wits Mining Limited is worth a buy ... if you can get your hands on it that is.
Shares of Novavax Inc. traded 10% higher after the firm confirmed that the European Medicines Agency is now reviewing its COVID-19 vaccine filing for conditional marketing authorization. The firm advised that an opinion from the agency is expected within a few weeks.
White Gold encountered two types of mineralization in a newly identified breccia unit at Betty Ford, a Stifel report noted.
Expert analyst Ron Struthers — founder and editor of Struthers' Resource Stock Report — breaks it all down, in a November 15 report, about what makes Inomin Mines Inc. his latest pick.
"A joint venture partnership would arguably be the single largest and most important derisking event in Seabridge Gold's history and as such, the upside ahead of a partnering event is potentially massive," noted a Cantor Fitzgerald report.
Market Overreacts to Silver Producer's Setback (11/16/2021)
Adrian Day of Global Analyst delves into what the denial of the renewal of a mining permit in Mexico means for Fortuna Silver.
Shares of Kezar Life Sciences Inc. rose to a new 52-week high after the company reported promising interim results from its Phase 2 trial of KZR-616 in patients with lupus nephritis.
"Higher commodity prices are providing Gran Tierra Energy with additional financial flexibility to service debt and to fund growth in 2022," noted a Research Capital Corporation report.
Shares of EyePoint Pharmaceuticals Inc. reached a new 52-week intraday high after the company reported positive data from its Phase 1 DAVIO study of EYP-1901 in Wet AMD and announced plans to move forward to additional Phase 2 clinical trials in 2022.
"We believe this data begins to form the basis of an approvable program for Compass Pathways' COMP360" in this indication, noted a BTIG report.
In a recent conversation with Streetwise Reports, David Lucatch, CEO and president of Liquid Avatar, talked about the company's multifaceted approach to bringing blockchain technology to people's everyday experiences and transactions.
Small tech company Mineworx has partnered with a Tennessee recycling company to extract platinum and palladium from diesel catalytic converters in a ground-breaking method that bypasses smelting, a major polluter.
Junior Miner Monetizes Non-Core Assets (11/13/2021)
Quebec Precious Metals CEO Normand Champigny discusses how his company's sale of non-core assets is funding its gold exploration programs in the James Bay region of Quebec.
Contakt World plans to build a diversified health technology SaaS platform and address inequity of health access through technology.
Invitae Corp. reported Q3/21 financial results that highlighted an 89% YoY increase in billable volume to 296,000 tests. Ladenburg Thalmann & Co. Inc. stated in a research note that it has a "Buy" rating for the company with a $55.00/share price target.
It seems drilling at Regnault is going well for Kenorland Minerals, as JV Partner Sumitomo recently completed a C$5.2M strategic investment, something you don't see very often. As the summer program is now several months underway, the first results are expected in a few weeks. The Critical Investor discusses this and exploration at other projects with CEO Zach Flood.
Diamond drilling results from White Gold Corp.'s Ryan's Surprise and Ulli's Ridge targets demonstrate significant potential to increase the global resource from 1.5 Moz Au to over 2 Moz Au at the company's Golden Saddle/Arc property. Stifel Nicolaus Canada Inc. commented in a research note that it has a "Buy" rating for White Gold and that a re-rating for the firm's shares is likely should it reach the 2 Moz mark.
"Magna Gold should be trading at a premium to the peer group, and a rerating is imminent," an M Partners report noted.
HudBay Minerals is in full execution mode in terms of exploration, project advancement and landing new opportunities, according to a BMO Capital Markets report.
Quebec Precious Metals, formed by a merger of two mining companies, may be sitting on as much as 2 million ounces of gold at its Quebec properties.
Gold Reaches 'Escape Velocity' (11/11/2021)
Precious metals expert Michael Ballanger explains why he believes the precious metals are breaking free of the gravitational pull of the last 15 months and are in the early stages of escape velocity.
Stereotaxis Inc. shares traded higher after the company reported Q3/21 financial results and confirmed its FY/21 revenue guidance. The company added that it is sufficiently funded and is on pace towards doubling its system revenue in FY/22.
E2Gold Inc. Is at Another Great Buy Spot (11/11/2021)
Chart analyst Clive Maund explains in a quick update why he has also put E2Gold on his list as a great buy.
MAG Silver Corp. is now engaged in the pre-commissioning phases of its new 4,000 tpd mill at the Juanicipio JV Project in Fresnillo, Mexico that when finished is expected to provide the company with 9,000,000 ounces of pre-payable silver production each year.
MAG Silver Corp.'s Fresnillo joint venture project is on track heading towards annual production of 27 Moz Ag eq. Stifel Canada has issued a "Buy" rating for the company and recently added the company to its list of Top Picks for Q4/21.
Emerita Resources Corp. issued an update regarding the status of two ongoing independent court cases in Spain and its prospects for winning the tender for the Aznalcóllar project. Research Capital Corp. commented in a research note that it believes the company has at least an 80% probability of being successful in the cases and is maintaining a "Speculative Buy" rating for the company.
Shares of Seres Therapeutics Inc. traded 20% higher after the company reported Q3/21 financial results and announced it is partnering with Bacthera in Switzerland to manufacture medicine for use in c.Diff treatment.
Shares of Pretium Resources Inc. traded 17% higher after the company reported it entered into a binding agreement to be acquired by Newcrest Mining Ltd. of Australia for CA$18.50 in cash and shares. The transaction is valued at CA$3.5 billion and allows shareholders the choice of receiving all cash, shares in Newcrest or a 50% split of each.
Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment.
This cost mitigation will derisk Juanicipio plant commissioning and ramp-up expected by year-end 2021, noted an H.C. Wainwright & Co. report.
This Yukon Explorer Is a 'Strong Buy' (11/09/2021)
Sector expert Clive Maund says that White Gold Corp.'s fundamentals 'look impressive' and that 'fresh purchases are in order.'
"The fact that White Gold's drilling hit fairly wide zones of high grade at shallow depth bodes well for both the mineral endowment and mineability of the emerging zone," noted a Stifel report.
All that needs to be done beforehand is connecting to the Mexico power grid then no-load and water testing, noted a Cormark report.
Results expected are for trials of Jounce Therapeutics' two lead product candidates, vopratelimab and pimivalimab, both monoclonal antibodies, noted a ROTH Capital Partners report.
Autolus Therapeutics Plc. shares traded 28% higher after the company reported that Blackstone Life Sciences is investing up to $250 million in the firm to develop obe-cel in treatment of adult Acute Lymphoblastic Leukemia and advance its broader targeted T- Cell technology platform.
The Critical Investor discusses the status of the projects of Standard Lithium, one of the major lithium developers in the Americas, and lithium product pricing in this quick update.
McAlinden Research Partners explains that while climate related disruptions have become standard in the agricultural industry, a new catalyst has recently emerged that could keep futures contracts climbing next year.
As the world adopts Cleantech as a means to curb environmental pollution, U.S.-based Mineworx Technologies Ltd. (MWX:TSX.V) has found a technological replacement for the traditional mining of precious metals. Mineworx uses its unique cleantech to economically and cleanly extract platinum and palladium from spent diesel catalysts.
Shares of brand, generic and injectable drug maker Endo International traded 25% higher after the company reported Q3/21 financial results and raised its FY/21 revenue and EPS guidance.
Chris Temple of The National Investor profiles 10 companies in a variety of sectors on his recommended list. "I very much am of the view that a great many resource-oriented stories and the best companies have incredible futures ahead of them," he writes.
No ‘Better Opportunity’ Than This Gold Explorer (11/04/2021)
Has the Klondike Gold Rush 2.0 quietly begun? Modern technologies and a century of accumulated know-how are catalyzing new discoveries in the Yukon, and one company at the center of the action is White Gold Corp. CEO David D'Onofrio was bullish in an interview with Streetwise Reports: "From a risk/reward perspective, I can't think of a better opportunity."
As Meridian Mining has been pretty busy at its Cabaçal VMS Copper-Gold Project in Brazil lately, raising an oversubscribed C$10.38M, drilling world class gold intercepts (8m @ 71.3g/t Au), other visible gold and long copper intercepts, defining new targets and gold structures, and is increasing strike length of mineralized zones, the Critical Investor catches up with management to discuss ongoing developments in a rather extensive update.
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue.
In an Oct. 8, 2021, broadcast, Crescat Capital Geologic and Technical Director, Dr. Quinton Hennigh, discussed the cycles in the gold market since the 1970s and posited that the U.S. is on the verge of a bull run in the gold price and another "age of discovery."
Surgery Partners shares traded 18% higher after the company reported Q3/21 financial results that included a 12.7% increase in YoY revenue and a 6.2% increase in the number of same-facility procedures performed.
Wedbush Securities Inc. advised that global precision therapy company Blueprint Medicines Corp.'s therapeutic AYVAKIT is gaining traction in patients diagnosed with advanced systemic mastocytosis and gastrointestinal stromal tumors. Wedbush reiterated its Outperform rating for the company and raised its 12-month price target by $4.00 to $136.00 per share.
Gold Explorer in Ontario Recommended as a Buy (11/03/2021)
Chris Temple of The National Investor explains why he has put E2Gold on his buy list and why he believes E2Gold has the potential to multiply its resource base, and geologic expert Dr. Quentin Hennigh agrees. In a statement made today, Hennigh told Streetwise why E2 is a buying opportunity for long-term investors right now.
McAlinden Research Partners estimates it may be only a matter of time before psychedelics become part of a biotech boom.
With the three-sided amalgamation completed, trading in Allied Copper shares is set to resume on the TSX Venture Exchange on Thursday, Nov. 4.
Eloro Hits Bigly (11/03/2021)
Bob Moriarty of 321gold highlights recent assay results for an explorer that he believes is one of the best stories in the past 20 years.
12 Reasons Why Inflation Is Here to Stay (11/03/2021)
Kerry Lutz, the founder of the Financial Survival Network, delves into some of the factors that may be behind inflation.
According to Bob Moriarty of 321Gold, Granite Creek Copper "has to be one of the lowest market cap copper stories with a real asset."
In a recent conversation with the Westhaven Gold management team, they briefed Streetwise Reports on the latest findings at the Shovelnose gold project.
During Crescat Capital's Oct. 1, 2021, broadcast, the firm's geologic and technical director, Quinton Hennigh, provided an overview of a company Crescat recently invested in, highlighting why he is excited about it. He also gave updates on six other companies in Crescat's mining exploration portfolio and explained how laboratories assay core samples.
In an Oct. 8, 2021 broadcast, Crescat Capital's Portfolio Manager, Tavi Costa, and Chief Investment Officer, Kevin Smith, addressed stagflation in the U.S., the Federal Reserve's conundrum and the near-term expectations for precious metals prices.
Liberty Gold's "upcoming preliminary economic assessment on Black Pine, along with ongoing drilling updates, may represent meaningful catalysts to spur a rerate opportunity," noted a Haywood Securities report.
BTIG commented in a research report that Sigilon Therapeutics is developing a powerful and widely applicable "cell replacement in a bottle" as a potential functional cure for genetic diseases. BTIG advised it is initiating coverage on the company with a "Buy" rating and $14/share price target.
Shares of Rogers Corp. traded 30% higher after the company reported it entered into a definitive agreement to be acquired by DuPont in an all-cash transaction for $277.00 per share.
In an Oct. 1, 2021, broadcast, Crescat Capital's Portfolio Manager, Tavi Costa, and Chief Investment Officer, Kevin Smith, argued that precious metals offer investors incredible value, protection, and growth during periods of economic toil like what we are experiencing globally today and that gold and silver prices are poised to take off from their current lows.
Research Capital Corp. advised that Canadian oil and gas explorer and producer Pan Orient Energy Corp. may be "getting out while the getting is good," and is exploring opportunities to exit from its assets in Thailand and Canada.
With rising inflation, the gold price is a coiled spring. Senior and junior miners as shown in the TSX Venture index have begun to rally with anticipation. Inomin Mines has advanced stage projects in favorable jurisdictions and a very low valuation, writes Ron Struthers of Struthers Resource Stock Report.
South Star Battery Metals Offers Twenty-Fold Return (11/01/2021)
Bob Moriarty of 321gold profiles South Star Battery Metals' graphite project and explains why he believes this is the best company he has written about in 20 years.
Shares of ANI Pharmaceuticals Inc. traded 50% higher after the company reported the U.S. FDA approved its Purified Cortrophin Gel for use in treating multiple sclerosis, rheumatoid arthritis and nephrotic syndrome.
|"SYH acquired a 51% interest in the Russell Lake uranium project."|
|"WCU confirmed three potential growth drivers for its Zonia project."|
|"We have a Buy recommendation on JEV."|
|"RHT is rated an Immediate Buy here."|
|"OCG discovered its 11th high grade vein at the Santa Ana project."|